Sitemap

Sitemap

Posts

Pages

#HowMuchIsEnough Awareness Campaign
Thank You
Fundraising
- In Memoriam
- Legacy Gifts
- Tell us your story
- Guide to Fundraising
- Take on a challenge event
- Sponsored Head Shave
- Coffee morning or afternoon tea
- Woburn Abbey Triathlon
- Skydive
- Mount Everest
- Weddings
- Corporate Partnerships
Shop
Cart
Checkout
My account
Sitemap
Training plans
Triathlon Kit
Sun Safety & Skin Awareness
Donate
Home
- About Us
  - Privacy Notice and Disclaimer
- Contact Us
- Objectives
- Specialist Committees
Information & Support
- Video: Immunotherapy Treatment for Patients
- What is Melanoma?
- Summaries of Scientific Papers
  - Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary
  - Overcoming Resistance to Dabrafenib: Lay Summary
- Taking Part in Clinical Trials: Video
- Library
  - Melanoma Focus Booklet
  - Melanoma World Society Newsletters
- AVAST-M Trial – Final Results Announced
- Melanoma Taskforce Report
  - Melanoma Care Pathway
- Weblinks
- Other Organisations
- Clinical Trials
- Patient Decision Aid
News & Updates
- News & Updates
- Access for Patients to New Drug Combinations
Support
- Helpline – 0808 801 0777
- Cambridge Melanoma Support Group
- Understanding sunbeds
Trustees, Management & Advisers
Activities
- Summary: What We Do
- Mucosal Melanoma Guidelines Project
  - Mucosal Melanoma Guidelines – Resources
- Research: Patient Impact Programme
- Uveal Melanoma Guidelines Project
- Melanoma Database Project
Meetings
- Events Calendar
- Subscription Rates and Registering for Meetings as a Non-Member
- Registering for Meetings as a Member
- Regional Meeting, Leeds, 17 May 2019 – Save the Date
- Focus on Melanoma Meeting, 11 October 2018
- 2017 Focus on Melanoma Meeting Papers
Members’ Area
- Professional Membership of Melanoma Focus
- Newcastle University’s Melanoma Ulceration Study: Technical Overview
- Follow-Up of High Risk Cutaneous Melanoma: Position Paper
- Overcoming Resistance to Dabrafenib: Technical Summary

Events

News

Flu vaccination: melanoma immunotherapy patients advised they should still receive jab

Immunology expert Professor Christian Ottensmeier says he believes that for these patients there is more harm in NOT vaccinating against flu than there is in vaccinating against it: ‘For inactivated vaccines such as the flu, I tell my patients to continue to have this form of protection.’

First safe and effective adjuvant therapy for melanoma is now available on the NHS

Patients and clinicians have welcomed the announcement of a new adjuvant therapy drug combination. ‘This is the first treatment to be made available that shows a significant reduction in the risk of dying from the recurrence of melanoma after surgery,’ says Melanoma Focus Chairman Professor Paul Lorigan. ‘This milestone will transform outcomes for many patients’.

‘How Much Is Enough’ melanoma awareness campaign launches

#howmuchisenough Altruist Sunscreen and Melanoma Focus unite to raise awareness of the dangers of sun damage and tanning. The campaign hits back with a new series of ‘scars and all’ content shorts to tell the human stories behind three common skin cancer cases.

Fundraising Events

100 Miles in May Challenge Event

100 Miles in May is a challenge event that anyone can take part in whether they are a cyclist, runner, walker or swimmer. Join the challenge and help raise money in the fight against melanoma.

Professional Events

Tweets